- What are the facilitators and barriers to using the PDMP (prescription drug monitoring program) generally and to inform surveillance and responses to the opioid problem?
- To what extent do users of the PDMP have adequate training and education?
- Does Alaska’s Controlled Substances Act provide an efficient and effective process for scheduling novel psychoactive substances and analogues?
- To what extent has the Good Samaritan statute been implemented, and are Alaskans aware of the statute?
Project Design: This project involves evaluation of policies designed to address opioids and heroin in Alaska. Policies that have been evaluated include the PDMP, Controlled Substances Act, and the Good Samaritan statute. In addition, a statute compilation and gap analysis of related policies has been conducted. The policy evaluation included key informant interviews and a content analysis of relevant committee meeting minutes.
Funding Source: Centers for Disease Control and Prevention is the funder, and the State of Alaska is the prime grantee. The State of Alaska contracts with University of Alaska Anchorage (UAA’s Institute of Social and Economic Research). NPC has a sub-award from UAA.
Start Date: September 2017
Rae Trotta, M.P.H.